-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Addex Therapeutics, Maintains $30 Price Target

Benzinga·10/02/2024 10:39:18
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Addex Therapeutics (NASDAQ:ADXN) with a Buy and maintains $30 price target.